Malta - angļu - Medicines Authority

medicem limited 57a ta’ maggi industrial estate, st. leonard street, xghajra l/o zabbar, zbr 2305, malta - film-coated tablet - metronidazole 200 mg - antibacterials for systemic use

Filipīnas - angļu - FDA (Food And Drug Administration)

sanofi-aventis philippines inc. - metronidazole - film-coated tablet - 500 mg

Saūda Arābija - angļu - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

sanofi-aventis, france - metronidazole - film-coated tablet - 250 mg

Saūda Arābija - angļu - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

sanofi-aventis, france - metronidazole - film-coated tablet - 500 mg

Saūda Arābija - angļu - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

sanofi-aventis - metronidazole - film-coated tablet - 500 mg

Saūda Arābija - angļu - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

sanofi-aventis - metronidazole - film-coated tablet - 250 mg

Malta - angļu - Medicines Authority

medicem limited 57a ta’ maggi industrial estate, xghajra, malta - metronidazole - film-coated tablet - metronidazole 400 milligram(s) - antibacterials for systemic use

Malta - angļu - Medicines Authority

ecosse limited “mangion building”, new street off valletta road, luqa, lqa 6000, malta - metronidazole - film-coated tablet - metronidazole 400 mg - antibacterials for systemic use

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - ornidazole 500mg;   - film coated tablet - 500 mg - active: ornidazole 500mg   excipient: hypromellose 60 sh hypromellose 6 cp magnesium stearate maize starch microcrystalline cellulose purified talc titanium dioxide - bacterial vaginosis (non-specific vaginitis).

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

pfizer laboratories div pfizer inc - metronidazole (unii: 140qmo216e) (metronidazole - unii:140qmo216e) - metronidazole 250 mg - flagyl is indicated for the treatment of t. vaginalis infection in females and males when the presence of the trichomonad has been confirmed by appropriate laboratory procedures (wet smears and/or cultures). flagyl is indicated in the treatment of asymptomatic t. vaginalis infection in females when the organism is associated with endocervicitis, cervicitis, or cervical erosion. since there is evidence that presence of the trichomonad can interfere with accurate assessment of abnormal cytological smears, additional smears should be performed after eradication of the parasite. t. vaginalis infection is a venereal disease. therefore, asymptomatic sexual partners of treated patients should be treated simultaneously if the organism has been found to be present, in order to prevent reinfection of the partner. the decision as to whether to treat an asymptomatic male partner who has a negative culture or one for whom no culture has been attempted is an individual one. in making this decision, it should be noted th